Royalty Pharma PLC at Evercore ISI Healthcare Conference Transcript
(technical difficulty) Conference hosting Royalty Pharma plc; Terrance Coyne, CFO; Marshall Urist, EVP of our investments. Gentlemen, welcome. Thank you so much for making time to be with us at this conference.
Before we get into Q&A, we'd just love to hear your kind of state of the union of the business and what we could be forward to in the next 12 months.
Yeah. So Thanks, Mike and Umer and Evercore for having us. I think 2025 has been a pretty amazing year for Royalty Pharma, a transformational year. We started the year off with a bang when we announced the major strategic transaction where we internalized our external manager put the company together as one consolidated business, which was really important from a strategic and from a financial perspective.
And then we've had a lot of great deals throughout the year, returned a record amount of capital to shareholders and have performed really well financially. So overall, I feel like
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
